Interactive program
Tuesday 21 March 2023
-
Standard presentation 400 Hall
Afternoon (CET)
FUTURE SEPSIS THERAPIES
Moderator(s):
Rinaldo Bellomo (Melbourne, Australia)
Bruno François (Limoges, France)
Bruno François (Limoges, France)
-
-
Focus on disease tolerance in sepsis
Christopher Seymour (Pittsburgh, United States)
Wednesday 22 March 2023
-
Standard presentation Gold Hall
Afternoon (CET)
PERSONALIZING THE CHOICE OF IV FLUID
Moderator(s):
Ashish K Khanna (Winston-Salem, United States)
Nathan Shapiro (Boston, United States)
Nathan Shapiro (Boston, United States)
-
-
Why not plasma in sepsis?
Christopher Seymour (Pittsburgh, United States)
-
Standard presentation Copper Hall
Morning (CET)
ARE OUR SYNDROMES STILL USEFUL?
Moderator(s):
Lieuwe Bos (Amsterdam, Netherlands)
Manu Shankar–Hari (Edinburgh, United Kingdom)
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
-
Sepsis subtypes
Christopher Seymour (Pittsburgh, United States)
-
Standard presentation Copper Hall
Afternoon (CET)
CLINICAL TRIALS
Moderator(s):
Jan Bakker (New York, United States)
Hallie Prescott (Ann Arbor, United States)
Hallie Prescott (Ann Arbor, United States)
-
-
Novel trial designs should include phenotypes
Christopher Seymour (Pittsburgh, United States)